Adelaide Research & Scholarship
Statistics
Total Visits
| Views | |
|---|---|
| Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase(legacy) | 146 |
| Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase(legacy) | 123 |
Total Visits per Month
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase | 0 | 3 | 1 | 2 | 1 | 5 | 2 |
File Downloads
| Views |
|---|
Top Country Views
| Views | |
|---|---|
| Australia | 98 |
| United States | 73 |
| China | 15 |
| France | 10 |
| Netherlands | 8 |
| Vietnam | 4 |
| Germany | 3 |
| Morocco | 2 |
| Sweden | 2 |
| Argentina | 1 |
Top City Views
| Views | |
|---|---|
| Kaleen | 52 |
| Ashburn | 33 |
| Fairfield | 10 |
| Rotterdam | 8 |
| Beijing | 4 |
| Hanoi | 4 |
| Cambridge | 2 |
| New York | 2 |
| Temara | 2 |
| Zhengzhou | 2 |